Loading...
Loading...
Barclay's initiated Ceres
CERE coverage with an Overweight rating and $18 price target in a research report published today.
In the report, Barclay's targeted three areas of value for the company in energy crops, biotech traits, and the company's opportunity to sell sorghum in Brazil.
Barclay's also stated that Ceres' biofuel and biopower crops may have "significant upside" in future years.
Shares of Ceres were trading at $10.03 at the time of posting, down 2.72% from Thursday's market close.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in